Introduction. The replacement of 24-h urine collection by protein-creatinine ratio (PCR) for the diagnosis of preeclampsia has been recently recommended. However, the literature is conflicting and there are concerns about the impact of demographic characteristics on the performance of PCR. Material and methods. This was an implementation audit of the introduction of PCR in a London Tertiary obstetric unit. The performance of PCR in the prediction of proteinuria ≥300 mg/day was assessed in 476 women with suspected preeclampsia who completed a 24-h urine collection and an untimed urine sample for PCR calculation. Multivariate logistic regression was used to assess the independent predictors of significant proteinuria. Results. In a pregnant population, ethnicity and PCR are the main predictors of ≥300 mg proteinuria in a 24-h urine collection. A PCR cut-off of 30 mg/mmol would have incorrectly classified as non-proteinuric, 41.4% and 22.9% of black and non-black women, respectively. Sensitivity of 100% is achieved at cut-offs of 8.67 and 20.56 mg/mmol for black and non-black women, respectively. Applying these levels as a screening tool to inform the need to perform a 24-h urine collection in 1000 women, would lead to a financial saving of €2911 in non-black women and to an additional cost of €3269 in black women. Conclusions. Our data suggest that a move from screening for proteinuria with a 24-h urine collection to screening with urine PCR is not appropriate for black populations. However, the move may lead to cost-saving if used in the white population with a PCR cut-off of 20.5.
Introduction
Preeclampsia (PE) is one of the leading causes of maternal mortality and the primary cause of iatrogenic preterm delivery, accounting for 18% of maternal deaths worldwide, and 40% of preterm deliveries and 5% of stillbirths in the UK (1) (2) (3) . Early diagnosis of PE
Key message
In pregnancy, protein-creatinine ratio has 100% sensitivity in the detection of ≥300 mg proteinuria in a 24-h urine collection at a cut-off of 20.5 mg/mmol and is cost-efficient in non-black women. In black women its performance is clinically and financially suboptimal.
is important in order to instigate close follow up of the pregnancy and timely planning of delivery. The cornerstones of screening for PE are the measurements of maternal blood pressure and proteinuria, with 300 mg of protein excretion in a 24-h urine collection being traditionally considered to be the cut-off for the diagnosis of PE in the presence of maternal hypertension (4) (5) (6) (7) .
However, the high costs, cumbersome methodology and compliance concerns with the traditional 24-h urine collection have led, outside pregnancy, to the introduction of the ratio of urine protein or albumin to creatinine as the preferred tools for assessment of proteinuria in adults (8, 9) . Similarly, in pregnancy, the use of protein-to-creatinine ratio (PCR) has been recommended by many professional bodies as an acceptable alternative to the 24-h urine collection for the assessment of proteinuria (4, 6, 7) , with a cut-off of 30 mg protein/mmol creatinine as the optimal cut-off to detect 300 mg of protein excretion in a 24-h urine collection (10) .
The concept of using PCR or albumin-to-creatinine ratio for assessing proteinuria was based on the assumption that daily creatinine urinary excretion is stable, as it is mainly related to muscle mass (11, 12) . Therefore, as proteinuria potentially increases, a stable creatinine in the denominator of the ratio acts as a control for the bias introduced by diurnal changes in hydration. However, more recently there has been evidence that urinary creatinine excretion also has a diurnal variation and, more importantly, is dependent on filtration rate, gender, race, body mass index and age (11, 12) . It is not a surprise, therefore, that the performance of PCR or albumin-to-creatinine ratio as screening tools for proteinuria is suboptimal in black vs. white populations and in the presence of significant proteinuria in certain diseases (13) (14) (15) .
Following the 2010 NICE guidance that PCR was a valid alternative to 24-h collection for assessment of proteinuria in pregnancy (6), we attempted to introduce this in routine clinical practice in our maternity unit. However, being aware of the potential pitfalls of using PCR in an antenatal population where 50% of them are of black-African or Afro-Caribbean origin, we audited the safety and financial impact of replacing 24-h urine collection by PCR for the first two years of its introduction.
This manuscript reports the results of the audit assessing the performance of PCR to predict proteinuria of ≥300 mg in a 24-h concentration in an antenatal population and comparing its cost-efficiency in black and nonblack populations.
Material and methods

Study population
The antenatal hypertension clinic at King's College Hospital is a dedicated clinic for the management of pregnancies complicated by hypertension. Based on local protocols, women with an increased risk of hypertensive complications, such as chronic hypertension or a history of hypertension in a previous pregnancy, are referred at booking to exclude secondary causes of hypertension and optimize pregnancy management. In addition, women with new onset hypertension during their pregnancy are also referred for risk assessment, treatment and follow up until delivery.
This was a prospective audit of 476 women attending the antenatal hypertension clinic consecutively between January 2011 and December 2012. Women with chronic hypertension with suspected superimposed PE (n = 180) or with new onset hypertension or proteinuria (n = 296) were asked to complete a 24-h urine collection as outpatients and deliver it the following day. In addition, each patient provided a urine sample for the calculation of the PCR immediately after the completion of the 24-h urine collection. The urine samples for PCR were not early morning samples as we wanted our sampling to be random, reflecting routine clinical practice.
Protein, creatinine and blood pressure measurement
Urinary protein quantitation was determined by the pyrogallol red molybdate dye-binding assay with the Advia 2400 analyzer (Siemens Healthcare, Frimley, Surrey) (16) and urinary creatinine was determined by the modified Jaffe's reaction (17) . Maternal blood pressure was measured in the sitting position, following the guidelines of the British Hypertension Society(18) with an automated device validated for use in pregnancy and PE (19) .
Outcome measures
The main outcome measure was the performance of the PCR to predict a 24-h urine collection above 300 mg/ 24 h for the whole cohort and separately in women of different ethnic backgrounds.
The costs of 24-h urine collection and PCR were calculated in detail and used to inform a cost of analysis for the use of PCR as a screening tool for a 24-h urine collection >300 mg/24 h.
Data collection and definitions
The maternal demographic characteristics were recorded on the day of the first visit, and outcome data were collected from local departmental databases. The maternal demographic details included the following variables: age, height, weight, body mass index, racial origin (white, black, other), cigarette smoking during pregnancy (yes or no), medical history (including chronic hypertension, asthma, renal disease, diabetes mellitus), medication (including anti-hypertensives, anti-asthmatics, anti-diabetics), parity (nulliparous, parous with no previous hypertension in pregnancy, parous with previous hypertension in pregnancy). Maternal demographics for the whole cohort and separately for white, Afro-Caribbean and women with other ethnic backgrounds are described in Table 1 .
A cut-off of 300 mg/24 h was used to define an abnormal 24-h urine collection, as this is the threshold recommended by national bodies in the USA and UK to define significant proteinuria in pregnancy and establish the definition of PE (4, 6) .
The definition of PE was that of the International Society for the Study of Hypertension in Pregnancy (5). The gestational age was confirmed by first trimester ultrasound.
Statistical analyses
The normality of the distribution of the data was assessed by the Kolmogorov-Smirnov test. For continuous numerical data, the Mann-Whitney U-test and the unpaired t-test were used to compare non-normally and normally distributed data, respectively. For categorical variables, the Chi-square test or Fisher's exact test, where appropriate, was used to assess the differences in proportions between groups.
Univariate and multivariate logistic regression analyses were used to establish the factors that independently predict proteinuria ≥300 mg in 24-h urine collection. The predictors were maternal height, weight, age, chronic hypertension, gestation at referral and protein-creatinine ratio. The performance of the prediction models are presented by their receiver operating characteristic (ROC) curves and the areas under the ROC curves (AUROC) were compared as described by DeLong et al. (20) .
We used a preliminary dataset of 200 patients to calculate the required sample size for the comparison of the ROC curves between black and non-black populations, as described by Hanley et al. (21) . For a Type I error (alpha) of 0.05 and type II error of 0.05 (i.e. power of 95%) at least 92 patients with proteinuria of ≥300 mg/24 h and 276 patients with proteinuria of <300 mg/24 h were needed to be recruited to prove that an area under the curve (AUC) of 0.97 was significantly different from a receiver operating characteristic (ROC) of 0.88. 
Ethical approval
For the current study, the advice of our Local Research and Development Committee and the Local Research Ethics Committee (London-Dulwich NRES Committee, 22-02-2017) was sought, and we were advised that formal consideration would not be required.
Results
Demographic and urinalysis results
This prospective audit included 476 women who were referred for the management of their pregnancies. The cohort included 204 women of white, 239 women of black and 33 women with other (mixed) ethnicity. The demographic characteristics, pregnancy outcomes and 24-h and PCR results of the whole cohort and the three ethnic groups of women are presented in Table 1 .
Compared with black women, white women had a lower weight and body mass index and presented later in gestation. They had a lower prevalence of previous hypertension in pregnancy and of chronic hypertension but a higher prevalence of renal disease and current pregnancy hypertension. They had a lower prevalence of PE but a higher prevalence of pregnancy-induced hypertension. White women also had a lower concentration of protein in their 24-h urine collection but similar volumes of urine and PCR values.
Compared with women of other ethnicity, white women were slightly taller and had a lower prevalence of chronic hypertension and diabetes but a higher prevalence of pregnancy-induced hypertension. Also compared with women with other ethnicity, black women were less likely to be nulliparous and had a higher prevalence of PE. Because women of other (mixed) ethnicity had similar proteinuria at presentation (both 24-h and PCR) and PCR performed equally well as in white women in the prediction of proteinuria <300 mg/24 h (data not presented), they were grouped for the remainder of the analysis with the white women.
Of the 476 women that participated in the audit, 106 had at least 300 mg and 370 had <300 mg proteinuria in their 24-h urine collection. Their demographic characteristics, pregnancy outcomes, and 24-h and PCR results are presented in Table 2 .
Women with significant proteinuria presented later in their pregnancy and were more likely to be black (Table 2) . They were eventually all classified as preeclamptic, apart from one woman with renal disease and stable proteinuria and three women with proteinuria, who remained normotensive. Women with at least 300 mg proteinuria, compared with those with proteinuria <300 mg/24 h, had a higher protein concentration and urine volume in their 24-h urine collections. They also had higher protein concentration and protein/creatinine ratios in their PCR collections (Table 2 ).
Prediction models and ROC
In the whole cohort, in a multivariate logistic regression model including maternal age, height, weight, chronic hypertension, black ethnicity, gestational age at referral and PCR, the only independent variables for the prediction of proteinuria ≥300 mg/24 h were maternal weight, black ethnicity and PCR (logitProteinuria = À7.3 + 0.02*weight + 1.2*Black + 0.1*PCR; p < 0.0001, Nagelkerke R 2 = 0.64, AUROC 0.94). In a univariate model (Table 3 , Figure 1 ), PCR alone had a similar performance to the multivariate model (logitProteinuria = À4.4 + 0.1*PCR, p < 0.0001, Nagelkerke, R 2 = 0.57, AUROC 0.92). The difference between the two AUROCs did not reach statistical significance (p = 0.1).
In non-black women (Table 3 , Figure 2 ) in a multivariate logistic regression model including maternal age, height, weight, chronic hypertension, gestational age at referral and PCR, the only independent variable for the prediction of proteinuria ≥300 mg/24 h was PCR (logitProteinuria = À6.1 + 0.1*PCR, p < 0.0001, Nagelkerke R 2 = 0.71, AUROC 0.97). In black women, in a multivariate logistic regression model including maternal age, height, weight, chronic Table 2 . Demographic characteristics and pregnancy outcomes between women with proteinuria ≥300 and <300 mg/day at the 24-h urine collection. Normally distributed data presented as mean (standard deviation) and non-normally distributed data as median (interquartile range). Categorical variables presented as n (%). hypertension, gestational age at referral and PCR, the only independent variables for the prediction of proteinuria ≥300 mg/24 h were maternal weight and PCR (logitProteinuria = À6.6 + 0.03*weight + 0.1*PCR; p < 0.0001, Nagelkerke R 2 = 0.55, AUROC 0.90). In a univariate model (Table 3 , Figure 2 ), PCR alone had a similar performance to the multivariate model (logitProteinuria = À3.5 + 0.1*PCR, p < 0.0001, Nagelkerke R 2 = 0.57, AUROC 0.90). The difference between the two AUROCs did not reach statistical significance (p = 0.6).
For a PCR cut-off of 30 mg/mmol, the sensitivity for the prediction of proteinuria ≥300 mg/24 h was 64.7, 77.1 and 58.6% for the whole cohort, non-black and black women, respectively ( Table 4 ). The PCR cut-off which provides 100% sensitivity for the whole cohort and black women was >8.67 mg/mmol and for non-black women 20.56 mg/mmol. At these cut-offs, the specificity would be 16.6, 82.7 and 24.2% for the whole cohort, non-black and black women, respectively (Table 4) .
Cost analysis
The cost analysis is presented in a hypothetical population of 1000 non-black and 1000 black women, in order to simplify the presentation of the results (Figure 3) . Assuming the 14.8 and 29.7% prevalence of significant proteinuria in non-black and black women in our study, respectively, represent population prevalence, we would expect 148 non-black and 297 black women with significant proteinuria in the two ethnic groups. With a PCR cut-off of 30 mg/mmol as a cut-off for the diagnosis of proteinuria we would have diagnosed correctly 114 nonblack and 175 black women, missing the diagnosis in 34 non-black and 122 black women, respectively. Furthermore, we would have falsely diagnosed as proteinuric 40 non-black and 70 black women, respectively.
As the sensitivity and false positive rates are suboptimal for the use of PCR as a first line diagnostic test, we wanted to test the cost-efficiency of a two-stage screening process, with PCR as first line and 24-h urine collection for those above the threshold that provides 100% sensitivity. The cost for the analysis of protein excretion in a 24-h urine collection was calculated locally at €10.48 and of a random specimen for PCR at €5.78 (data not presented). Based on these calculations, assuming a population of 1000 non-black pregnant women, using a cut-off of 20.56 mg/mmol would provide a sensitivity of 100% in the detection of proteinuria ≥300 mg/24 h and would lead to a saving of €2911.1 (Figure 3) . Conversely, assuming a population of 1000 black pregnant women, using a cut-off of 8.67 mg/mmol would provide a sensitivity of 100% in the detection of proteinuria ≥300 mg/24 h but would lead to an additional cost of €3269.4 ( Figure 3) .
Discussion
This study has demonstrated that in a pregnant population, maternal ethnicity, PCR and weight are independent predictors of ≥300 mg proteinuria in a 24-h urine collection. The two former variables contribute the most in the model, with weight having minimal impact. In the total population, a PCR cut-off of 30 mg/mmol to inform the need to perform a 24-h urine collection has a 64.7% Table 3 . Odds ratios (95% CI) and areas under the receiver operating characteristic curves (AUROC, 95% CI) for the whole cohort, non-black and black women for the prediction of a 24-h of ≥300 mg/24 h using the protein/creatinine ratio. sensitivity, leading to erroneous classification of 35.3% of the population as non-proteinuric. More specifically, with a PCR cut-off of 30 mg/mmol, 41.4 and 22.9% of black and non-black women with proteinuria, respectively, would have been incorrectly classified as non-proteinuric. The false-positive rate is also raised, implying that 4% of non-black and 7% of black women would have been erroneously classified as proteinuric, leading to unnecessary clinical interventions. In a unit with an ethnically diverse population, consisting of a significant proportion of women of black ethnicity, there are three options to diagnose significant proteinuria: first, to use only 24-h urine collections accepting the cost implications and methodological concerns; secondly, to use only PCR as a diagnostic test accepting the poor sensitivity and high false-positive rates in the black ethnic groups; thirdly, to use PCR as a first line screening tool to advise on who needs to undergo a 24-h urine collection. On this occasion, using PCR in 1000 non-black women as a primary screening tool to inform the need to perform a 24-h urine collection, a cut-off 20.56 mg/mmol would provide 100% sensitivity and with local estimates would lead to a saving of €2911, whereas in 1000 black women, a cut-off 8.67 mg/mmol would provide 100% sensitivity and with local estimates would lead to an additional loss of €3269.
Since 1990, when the first publication suggested that the use of PCR for the assessment of proteinuria in pregnancy may be a simple alternative to 24-h urine collection (22) , there have been more than 25 studies assessing the performance PCR in the prediction of ≥300 mg proteinuria in a 24-h urine collection. The most pertinent studies are summarized in four systematic reviews (23) (24) (25) (26) that illustrate the significant variation in the performance of PCR and different cut-offs suggested for the prediction of significant proteinuria in pregnancy. Suggested cut-offs, sensitivities and specificities ranged between 17 and 57 mg/mmol, 72.6 and 98.0%, and 41 and 100%, respectively. Studies based in Australia (10), Thailand (27) , Latin America (28) (29) (30) , Canada (31) and USA (32, 33) reported sensitivities above 90%, whereas others from Turkey (34), Iran (35) and USA (36, 37) have Table 4 . Sensitivity (95% CI) and specificity (95% CI) for the whole cohort, non-black and black women for the prediction of a 24-h of ≥300 mg/24 h. Data presented at the cut-off which provides 100% sensitivity, at the optimal criterion on each ROC curve, and for a cut-off of 30 mg/mmol. The cut-off which provides 100% sensitivity for the whole cohort and black women was >8.67 mg/mmol and for non-black women 20.56 mg/mmol. The optimal criterion for the whole cohort was 20.56 mg/mmol, for non-black women 25.15, and for black women 19.03 mg/mmol. reported sensitivities ranging between 72.6 and 86.8%. In all but two studies (10, 28) , the sensitivities reported were achieved at thresholds considerably below 30 mg/mmol (range 17-21 mg/mmol) and in two of them at cut-offs of 44 (36) and 57 (29) mg/mmol. None of the above-mentioned studies examined the effect of ethnicity on the performance of PCR and very few even reported on the ethnicity of their population. There is only one study that reported an ethnic mix similar to that of our study. Durnwald et al. examined 220 women at risk of PE; 43.2% of them were of black ethnicity (36) . They reported a low correlation between PCR and 24-h urine protein concentration (r 2 = 0.41), a modest area under the ROC curve of 0.80; for a cut-off of 33.9 mg/mmol they reported a sensitivity and specificity of 81 and 55.8%, respectively. It was previously highlighted that black populations, controlling for height and weight, excrete more urinary creatinine compared with similar-sized white populations (11, 12) . It is therefore possible that this variation in creatinine excretion is the main cause for the limited performance of PCR in black women for the detection of significant proteinuria and that more research is needed on whether the PCR calculation needs adjustment for ethnicity in the same way as the estimated glomerular-filtration rate (38) .
From the systematic reviews of the above-mentioned studies, summary measures of diagnostic accuracy for PCR to detect 300 mg or more of proteinuria in a 24-h urine collection ranged from 83 to 91% and 76 to 86% for sensitivity and specificity, respectively (23) (24) (25) (26) . These figures are extremely close to those measured our study for the total cohort. In clinical terms, if PCR in its current form were to replace 24-h urine collection, this would be an unacceptable compromise, since one would expect to underdiagnose PE by about 16% and classify 23% of non-proteinuric women as proteinuric. The impact of such an intervention would be a surge in adverse maternal outcomes, since lack of early recognition and treatment of the disease has been one of the contributory factors to maternal mortality. Similarly, misclassification of about of 23% of non-proteinuric patients as proteinuric, would lead to escalation of their surveillance, unwarranted interventions, and unnecessary strain and expenses to the maternity systems.
Our data suggest that the clinical and financial implications of the universal adoption of PCR at the recommended threshold of 30 mg/mmol as a screening tool for the detection of significant proteinuria in a high-risk population, with high prevalence of black ethnicity, needs further evaluation. A safer approach would be to restrict the use of PCR to non-black populations at a cut-off of 20.5 mg/mmol, and to persevere with further research in black populations to improve the performance of PCR in informing the need for performing a 24-h urine collection. Figure 3 . Cost-efficiency estimates in a hypothetical sample of 1000 women based on the prevalence of significant proteinuria in non-black (left) and black (right) pregnant women.
